Assessing heparin levels during cardiac bypass surgery: activated clotting time vs. anti-factor Xa level

被引：0
|
作者：
Sheppard, C. A. [1 ]
Tanaka, K. [1 ]
Fantz, C. R. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
C-119
引用
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time
    Coons, James C.
    Iasella, Carlo J.
    Thornberg, Megan
    Fitzmaurice, Mary Grace
    Goehring, Kimberly
    Jablonski, Lindsay
    Leader, Dominic
    Meyer, Abby
    Seo, Hangil
    Benedict, Neal J.
    Smith, Roy E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) : 1015 - 1019
  • [2] Components of variability of the effect of activated partial thromboplastin time vs. anti-factor Xa on unfractionated heparin dose adjustments
    Guerrero, F.
    Faucher, A.
    Diemert, V
    Voisin, S.
    Sie, P.
    Riviere, Bura A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 380 - 381
  • [3] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [4] Heparin concentrations in neonates during cardiopulmonary bypass as measured by the activated clotting time and anti-Xa assay
    Keogh, J.
    Davidson, S. J.
    Machin, M.
    Hall, J.
    Kelleher, A. A.
    ANAESTHESIA, 2009, 64 (12) : 1388 - 1389
  • [5] Components of variability of activated partial thromboplastin time (APTT) vs. anti-factor Xa (AXa) on unfractionated heparin (UFH) dose adjustments
    Guerrero, F.
    Faure, A.
    Diemert, V
    Voisin, S.
    Sie, P.
    Riviere, Bura A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 683 - 684
  • [6] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    CRITICAL CARE MEDICINE, 2020, 48
  • [7] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
  • [8] Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation
    Liveris, Anna
    Bello, Ricardo A.
    Friedmann, Patricia
    Duffy, Melissa A.
    Manwani, Deepa
    Killinger, James S.
    Rodriquez, Daniel
    Weinstein, Samuel
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : E72 - E79
  • [9] ANTI-FACTOR XA CLOTTING METHOD FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS
    HARENBERG, J
    GIESE, C
    KNODLER, A
    ZIMMERMANN, R
    ARZTLICHE LABORATORIUM, 1986, 32 (08): : 181 - 184
  • [10] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
12345